Avalon Trust Co Sells 478 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Avalon Trust Co trimmed its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.4% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 125,108 shares of the financial services provider’s stock after selling 478 shares during the period. iShares Biotechnology ETF makes up about 1.6% of Avalon Trust Co’s investment portfolio, making the stock its 22nd biggest position. Avalon Trust Co’s holdings in iShares Biotechnology ETF were worth $16,996,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in IBB. International Assets Investment Management LLC acquired a new position in iShares Biotechnology ETF in the fourth quarter worth about $76,425,000. Itau Unibanco Holding S.A. acquired a new position in shares of iShares Biotechnology ETF in the 3rd quarter worth approximately $48,242,000. Bank Julius Baer & Co. Ltd Zurich lifted its position in shares of iShares Biotechnology ETF by 3.7% during the 3rd quarter. Bank Julius Baer & Co. Ltd Zurich now owns 293,097 shares of the financial services provider’s stock worth $35,843,000 after buying an additional 10,542 shares during the period. Raymond James Financial Services Advisors Inc. boosted its stake in iShares Biotechnology ETF by 8.9% in the 4th quarter. Raymond James Financial Services Advisors Inc. now owns 153,692 shares of the financial services provider’s stock valued at $20,879,000 after buying an additional 12,611 shares in the last quarter. Finally, Albion Financial Group UT raised its stake in iShares Biotechnology ETF by 1.2% during the fourth quarter. Albion Financial Group UT now owns 129,377 shares of the financial services provider’s stock worth $17,576,000 after acquiring an additional 1,575 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Stock Up 1.8 %

Shares of NASDAQ:IBB traded up $2.31 on Friday, hitting $132.96. The stock had a trading volume of 1,804,184 shares, compared to its average volume of 1,700,513. The firm’s 50 day moving average price is $133.61 and its 200-day moving average price is $129.99. iShares Biotechnology ETF has a twelve month low of $111.83 and a twelve month high of $141.16.

iShares Biotechnology ETF Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were given a $0.126 dividend. The ex-dividend date of this dividend was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a yield of 0.38%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.